Literature DB >> 32470315

Adipose-Derived Mesenchymal Stromal Cells in Regenerative Medicine: State of Play, Current Clinical Trials, and Future Prospects.

Jérôme Laloze1,2, Loïc Fiévet3, Alexis Desmoulière1.   

Abstract

Significance: Wound healing is a complex process involving pain and inflammation, where innervation plays a central role. Managing wound healing and pain remains an important issue, especially in pathologies such as excessive scarring (often leading to fibrosis) or deficient healing, leading to chronic wounds. Recent Advances: Advances in therapies using mesenchymal stromal cells offer new insights for treating indications that previously lacked options. Adipose-derived mesenchymal stromal cells (AD-MSCs) are now being used to a much greater extent in clinical trials for regenerative medicine. However, to be really valid, these randomized trials must imperatively follow strict guidelines such as consolidated standards of reporting trials (CONSORT) statement. Indeed, AD-MSCs, because of their paracrine activities and multipotency, have potential to cure degenerative and/or inflammatory diseases. Combined with their relatively easy access (from adipose tissue) and proliferation capacity, AD-MSCs represent an excellent candidate for allogeneic treatments. Critical Issues: The success of AD-MSC therapy may depend on the robustness of the biological functions of AD-MSCs, which requires controlling source heterogeneity and production processes, and development of biomarkers that predict desired responses. Several studies have investigated the effect of AD-MSCs on innervation, wound repair, or pain management separately, but systematic evaluation of how those effects could be combined is lacking. Future Directions: Future studies that explore how AD-MSC therapy can be used to treat difficult-to-heal wounds, underlining the need to thoroughly characterize the cells used, and standardization of preparation processes are needed. Finally, how this a priori easy-to-use cell therapy treatment fits into clinical management of pain, improvement of tissue healing, and patient quality of life, all need to be explored.

Entities:  

Keywords:  adipose-derived mesenchymal stromal cell; advanced therapy medicinal product; pain; regenerative medicine; skin innervation; wound healing

Mesh:

Year:  2020        PMID: 32470315      PMCID: PMC7698876          DOI: 10.1089/wound.2020.1175

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  226 in total

1.  Stem cells and spinal cord repair.

Authors:  Evan Y Snyder; Yang D Teng
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

2.  Effect of fat particle-to-SVF ratio on graft survival rates in rabbits.

Authors:  Youdi Ni; Xiaosheng He; Zhijian Yuan; Maolin Liu; Hongying Du; Xiaochun Zhong
Journal:  Ann Plast Surg       Date:  2015-05       Impact factor: 1.539

3.  Conversion of Adipose Tissue-Derived Mesenchymal Stem Cells to Neural Stem Cell-Like Cells by a Single Transcription Factor, Sox2.

Authors:  Yiren Qin; Chikai Zhou; Nianhong Wang; Hao Yang; Wei-Qiang Gao
Journal:  Cell Reprogram       Date:  2015-06       Impact factor: 1.987

Review 4.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

5.  Neuron-like differentiation of adipose tissue-derived stromal cells and vascular smooth muscle cells.

Authors:  Hongxiu Ning; Guiting Lin; Tom F Lue; Ching-Shwun Lin
Journal:  Differentiation       Date:  2006-12       Impact factor: 3.880

6.  Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.

Authors:  A J Friedenstein; K V Petrakova; A I Kurolesova; G P Frolova
Journal:  Transplantation       Date:  1968-03       Impact factor: 4.939

Review 7.  Autologous adipose tissue grafting for the management of the painful scar.

Authors:  Kendrick To; Conor Crowley; Soo-Keat Lim; Wasim S Khan
Journal:  Cytotherapy       Date:  2019-09-17       Impact factor: 5.414

8.  An alternative method for the isolation of mesenchymal stromal cells derived from lipoaspirate samples.

Authors:  Leandra S Baptista; Ronaldo J F C do Amaral; Rosana B V Carias; Marcelo Aniceto; Cesar Claudio-da-Silva; Radovan Borojevic
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

Review 9.  Systematic review of patient factors affecting adipose stem cell viability and function: implications for regenerative therapy.

Authors:  Jajini Varghese; Michelle Griffin; Afshin Mosahebi; Peter Butler
Journal:  Stem Cell Res Ther       Date:  2017-02-28       Impact factor: 6.832

10.  Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action.

Authors:  Timothy Caulfield; Blake Murdoch
Journal:  BMC Med Ethics       Date:  2019-08-06       Impact factor: 2.652

View more
  4 in total

Review 1.  Role of adipose tissue grafting and adipose-derived stem cells in peripheral nerve surgery.

Authors:  Tiam M Saffari; Sara Saffari; Krishna S Vyas; Samir Mardini; Alexander Y Shin
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

2.  Clinical applications of adipose-derived stromal vascular fraction in veterinary practice.

Authors:  Khan Sharun; Kaveri Jambagi; Rohit Kumar; Mudasir Bashir Gugjoo; Abhijit M Pawde; Hardeep Singh Tuli; Kuldeep Dhama
Journal:  Vet Q       Date:  2022-12       Impact factor: 8.071

3.  S100A4 Silencing Facilitates Corneal Wound Healing After Alkali Burns by Promoting Autophagy via Blocking the PI3K/Akt/mTOR Signaling Pathway.

Authors:  Yulin Wang; Guiping Gao; Ying Wu; Yuqin Wang; Xiaorong Wu; Qiong Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

4.  Adipose-derived mesenchymal stem cell-loaded β-chitin nanofiber hydrogel promote wound healing in rats.

Authors:  Ying Liu; Yunen Liu; Mi Wu; Rufei Zou; Shun Mao; Peifang Cong; Mingxiao Hou; Hongxu Jin; Yan Zhao; Yongli Bao
Journal:  J Mater Sci Mater Med       Date:  2022-01-20       Impact factor: 3.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.